Details for Patent: 10,792,253
Which drugs does patent 10,792,253 protect, and when does it expire?
Patent 10,792,253 protects ATZUMI and is included in one NDA.
This patent has sixteen patent family members in ten countries.
Summary for Patent: 10,792,253
| Title: | Pharmaceutical compositions |
| Abstract: | Disclosed herein are pharmaceutical powder compositions, methods of making such compositions, and uses thereof. |
| Inventor(s): | Shunji Haruta |
| Assignee: | Shin Nippon Biomedical Laboratories Ltd |
| Application Number: | US15/668,871 |
|
Patent Claim Types: see list of patent claims | Composition; |
Drugs Protected by US Patent 10,792,253
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Satsuma Pharms | ATZUMI | dihydroergotamine mesylate | POWDER;NASAL | 217901-001 | Apr 30, 2025 | RX | Yes | Yes | 10,792,253 | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,792,253
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2017307306 | ⤷ Start Trial | |||
| Brazil | 112019002371 | ⤷ Start Trial | |||
| Canada | 3030359 | ⤷ Start Trial | |||
| China | 109640947 | ⤷ Start Trial | |||
| China | 122664939 | ⤷ Start Trial | |||
| China | 122786284 | ⤷ Start Trial | |||
| European Patent Office | 3493789 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
